Correlation Between Sonnet Biotherapeutics and Pulmatrix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Pulmatrix, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Pulmatrix.

Diversification Opportunities for Sonnet Biotherapeutics and Pulmatrix

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sonnet and Pulmatrix is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Pulmatrix go up and down completely randomly.

Pair Corralation between Sonnet Biotherapeutics and Pulmatrix

Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to generate 8.76 times more return on investment than Pulmatrix. However, Sonnet Biotherapeutics is 8.76 times more volatile than Pulmatrix. It trades about 0.12 of its potential returns per unit of risk. Pulmatrix is currently generating about -0.21 per unit of risk. If you would invest  122.00  in Sonnet Biotherapeutics Holdings on June 9, 2025 and sell it today you would earn a total of  163.00  from holding Sonnet Biotherapeutics Holdings or generate 133.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sonnet Biotherapeutics Holding  vs.  Pulmatrix

 Performance 
       Timeline  
Sonnet Biotherapeutics 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sonnet Biotherapeutics Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Sonnet Biotherapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Pulmatrix 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Pulmatrix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in October 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Sonnet Biotherapeutics and Pulmatrix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sonnet Biotherapeutics and Pulmatrix

The main advantage of trading using opposite Sonnet Biotherapeutics and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.
The idea behind Sonnet Biotherapeutics Holdings and Pulmatrix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas